These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12392315)

  • 1. Evaluation of two modified cardiac troponin I enzyme immunoassays.
    Haug C; Bachem MG; Woehrle H; Hetzel M; Gruenert A
    Clin Chem Lab Med; 2002 Aug; 40(8):837-9. PubMed ID: 12392315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of a revised cardiac troponin method that minimizes interferences from heterophilic antibodies.
    Kim WJ; Laterza OF; Hock KG; Pierson-Perry JF; Kaminski DM; Mesguich M; Braconnier F; Zimmermann R; Zaninotto M; Plebani M; Hanna A; Cembrowski GS; Scott MG
    Clin Chem; 2002 Jul; 48(7):1028-34. PubMed ID: 12089171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical performance and clinical decision limit of a new release for cardiac troponin I assay.
    Moretti M; Pieretti B; Sisti D; Rocchi M; Gasperoni S
    Ann Clin Biochem; 2015 Jan; 52(Pt 1):169-72. PubMed ID: 24711561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of the Advia Centaur second-generation troponin assay TnI-Ultra compared with the first-generation cTnI assay.
    van de Kerkhof D; Peters B; Scharnhorst V
    Ann Clin Biochem; 2008 May; 45(Pt 3):316-7. PubMed ID: 18482922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European multicenter analytical evaluation of the Abbott ARCHITECT STAT high sensitive troponin I immunoassay.
    Krintus M; Kozinski M; Boudry P; Capell NE; Köller U; Lackner K; Lefèvre G; Lennartz L; Lotz J; Herranz AM; Nybo M; Plebani M; Sandberg MB; Schratzberger W; Shih J; Skadberg Ø; Chargui AT; Zaninotto M; Sypniewska G
    Clin Chem Lab Med; 2014 Nov; 52(11):1657-65. PubMed ID: 24897400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of the Ortho Vitros cardiac troponin I assay in patients with symptoms of myocardial ischemia. Risk stratification using European Society of Cardiology/American College of Cardiology recommended cutoff values.
    Apple FS; Murakami MM; Quist HH; Pearce LA; Wieczorek S; Wu AH
    Am J Clin Pathol; 2003 Jul; 120(1):114-20. PubMed ID: 12866381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and analytical performance of the liaison cardiac troponin I assay in unstable coronary artery disease, and the impact of age on the definition of reference limits. A FRISC-II substudy.
    Venge P; Johnston N; Lagerqvist B; Wallentin L; Lindahl B;
    Clin Chem; 2003 Jun; 49(6 Pt 1):880-6. PubMed ID: 12765983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of Undetectable, Measurable, and Increased Cardiac Troponin I Concentrations Above the 99th Percentile Using a High-Sensitivity vs a Contemporary Assay in Patients Presenting to the Emergency Department.
    Love SA; Sandoval Y; Smith SW; Nicholson J; Cao J; Ler R; Schulz K; Apple FS
    Clin Chem; 2016 Aug; 62(8):1115-9. PubMed ID: 27324737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical evaluation of an automated immunoassay for cardiac troponin I: the Vidas Troponin I assay.
    Di Serio F; Trerotoli P; Serio G; Varraso L; Pansini N
    Clin Chem Lab Med; 2003 Oct; 41(10):1363-8. PubMed ID: 14580167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction.
    Keller T; Zeller T; Ojeda F; Tzikas S; Lillpopp L; Sinning C; Wild P; Genth-Zotz S; Warnholtz A; Giannitsis E; Möckel M; Bickel C; Peetz D; Lackner K; Baldus S; Münzel T; Blankenberg S
    JAMA; 2011 Dec; 306(24):2684-93. PubMed ID: 22203537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance characteristics of five cardiac Troponin I assays.
    La'ulu SL; Roberts WL
    Clin Chim Acta; 2010 Aug; 411(15-16):1095-101. PubMed ID: 20398643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct comparison of clinical decision limits for cardiac troponin T and I.
    Kimenai DM; Henry RM; van der Kallen CJ; Dagnelie PC; Schram MT; Stehouwer CD; van Suijlen JD; Niens M; Bekers O; Sep SJ; Schaper NC; van Dieijen-Visser MP; Meex SJ
    Heart; 2016 Apr; 102(8):610-6. PubMed ID: 26794233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction.
    Wu AH; Smith A; Christenson RH; Murakami MM; Apple FS
    Clin Chim Acta; 2004 Aug; 346(2):211-9. PubMed ID: 15256323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of high-sensitivity performance for a United States Food and Drug Administration cleared cardiac troponin I assay.
    Christenson RH; Mullins K; Duh SH
    Clin Biochem; 2018 Jun; 56():4-10. PubMed ID: 29750939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of minor elevation of cardiac troponin I].
    Jung CL; Cho SE; Hong KS
    Korean J Lab Med; 2008 Oct; 28(5):339-45. PubMed ID: 18971614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot study on harmonization of cardiac troponin I immunoassays using patients and quality control plasma samples. On behalf of the Italian Section of the European Ligand Assay Society (ELAS) and of the Study Group on Cardiovascular Biomarkers of the Società Italiana di Biochimica Clinica (SIBioC).
    Clerico A; Ripoli A; Masotti S; Prontera C; Storti S; Fortunato A; Buzzi P; Casagranda I; Franzini M; Ndreu R; Zucchelli GC; Zaninotto M; Plebani M
    Clin Chim Acta; 2016 May; 456():42-48. PubMed ID: 26923393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of antibody specificity and calibration material on the measure of agreement between methods for cardiac troponin I.
    Newman DJ; Olabiran Y; Bedzyk WD; Chance S; Gorman EG; Price CP
    Clin Chem; 1999 Jun; 45(6 Pt 1):822-8. PubMed ID: 10351991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of analytical performance of the Pathfast cardiac troponin I.
    Di Serio F; Caputo M; Zaninotto M; Ottomano C; Plebani M
    Clin Chem Lab Med; 2009; 47(7):829-33. PubMed ID: 19453290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differences in cardiac troponin I and T levels measured in asymptomatic hemodialysis patients with last generation immunoassays].
    Deléaval P; Descombes E; Magnin JL; Martin PY; Fellay G
    Nephrol Ther; 2006 May; 2(2):75-81. PubMed ID: 16895718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 99th percentile and imprecision of point-of-care cardiac troponin I in comparison to central laboratory tests in a large reference population.
    Greiser A; Winter T; Mahfoud H; Kallner A; Ittermann T; Masuch A; Lubenow N; Kohlmann T; Greinacher A; Nauck M; Petersmann A
    Clin Biochem; 2017 Dec; 50(18):1198-1202. PubMed ID: 28803961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.